CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study 期刊论文
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 卷号: 114, 期号: 3
作者:  He, Yao;  Zhu, Zhenhua;  Chen, Yujun;  Chen, Fang;  Wang, Yufang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study 期刊论文
2019, 卷号: 114, 期号: 3, 页码: 490-499
作者:  He, Yao;  Zhu, Zhenhua;  Chen, Yujun;  Chen, Fang;  Wang, Yufang
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Comparison of hepatotoxicity and mechanisms induced by triclosan (TCS) and methyl-triclosan (MTCS) in human liver hepatocellular HepG2 cells 期刊论文
TOXICOLOGY RESEARCH, 2019, 卷号: 8, 期号: 1, 页码: 38-45
作者:  Wang, Lu;  Mao, Boyu;  He, Huixin;  Shang, Yu;  Zhong, Yufang
收藏  |  浏览/下载：5/0  |  提交时间：2020/04/27
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study 期刊论文
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 卷号: 6, 期号: 1
作者:  Hu, Peng;  Shang, Jia;  Zhang, Wenhong;  Gong, Guozhong;  Li, Yongguo
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleoside Analog： New Switch Study 期刊论文
临床与转化肝病杂志(英文版), 2018, 卷号: 第6卷, 页码: 25-34
作者:  Peng Hu;  Jia Shang;  Wenhong Zhang;  Guozhong Gong;  Yongguo Li
收藏  |  浏览/下载：17/0  |  提交时间：2019/02/25
miR-449a inhibits colorectal cancer progression by targeting SATB2 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 60
作者:  Sun, Xiaohua;  Liu, Sanhong;  Chen, Pengfei;  Fu, Da;  Hou, Yingyong
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
miR-449a inhibits colorectal cancer progression by targeting SATB2 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 60
作者:  Zhan, Yu;  Hu, Yiming;  Li, Cuifeng;  Tao, Yu;  Jiang, Yuhang
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Increased and sustained HBsAg loss in HBeAg positive CHB patients switched from NUC to Peg-IFN alfa-2a: A randomised open label trial (NEW SWITCH study) 会议论文
作者:  Hu, Peng;  Dou, Xiaoguang;  Jiang, Jian-ning;  Jia, Shang;  Zhang, Wen Hong
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06
PREDICTIVE VALUE OF BASELINE AND ON-TREATMENT qHBsAg LEVEL IN HBeAg POSITIVE CHB PATIENTS WHO SWITCHED FROM NUCS TO PEGYLATED INTERFERON A-2A: A FURTHER ANALYSIS FROM NEW SWITCH STUDY 会议论文
作者:  Hu, P.;  Shang, J.;  Zhang, W.;  Gong, G.;  Li, Yongguo
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/19
A multi-center randomized study on the efficacy and safety of switching to peginterferon alpha-2a (40KD) for 48 or 96 weeks in HBeAg positive CHB patients with a prior NUC history for 1 to 3 years: an interim analysis of NEW SWITCH study 会议论文
作者:  Hu, Peng;  Jia, Shang;  Zhang, Wen Hong;  Gong, Guozhong;  Li, Yongguo
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace